The Silent Disease That Steals Limbs

What You Need to Know About Peripheral Artery Disease and Amputation

Every year in the United States, surgeons perform more than 150,000 lower-limb amputations. The majority are not the result of accidents or trauma. They are the result of a disease that crept through the body for years, quietly and without complaint, until the damage was irreversible.

That disease is peripheral artery disease, and it is one of the most underdiagnosed conditions in medicine today.

What Is Peripheral Artery Disease?

Peripheral artery disease, or PAD, is a circulatory condition in which plaque builds up in the arteries that carry blood to the legs and feet. That buildup, a process called atherosclerosis, gradually narrows the arteries and reduces blood flow to the lower extremities.

The feet and lower legs are at the end of a long supply chain. When that supply chain gets compromised, the tissue at the far end suffers first. Less blood means less oxygen. Less oxygen means tissue that cannot heal itself, cannot fight infection, and cannot survive injury the way healthy tissue does.

Over time, that process reaches a point of no return.

The Problem With PAD: You Often Cannot Feel It Coming

This is the part that makes PAD genuinely dangerous. Unlike a heart attack, which announces itself with crushing chest pain, PAD frequently produces no obvious symptoms in its early stages.

Research consistently shows that up to 50% of all people with PAD are completely asymptomatic. They do not experience the classic leg cramping during walking that textbooks describe. They do not feel pain at rest. They have no idea that blood flow to their feet is being strangled, slowly, year by year.

By the time symptoms appear, the disease has often been progressing for a decade or more. And for patients with diabetes, the situation is even more complicated. Diabetic neuropathy, the nerve damage that accompanies uncontrolled blood sugar, can mask the pain signals that might otherwise prompt someone to seek care. A diabetic patient with severe PAD may feel nothing while their foot is in serious arterial jeopardy.

How Undetected PAD Becomes an Amputation

The progression from undetected PAD to amputation does not happen overnight. It follows a path that, at nearly every stage, offers an opportunity for intervention. The tragedy is that most people never get that opportunity because no one tested them.

Here is how it unfolds.

The arteries narrow. Blood flow to the lower leg and foot decreases. For a while, the body compensates. Collateral vessels develop. The patient feels fine.

Then something disrupts the equilibrium. A minor foot injury. A blister from a new pair of shoes. A small cut that a person with normal circulation would barely notice. In a healthy foot, the healing process begins immediately. White blood cells rush to the site. New tissue forms. The wound closes in days.

In a foot with severely reduced blood flow, that response never arrives. The wound does not close. It becomes an ulcer. The ulcer becomes infected. Bacteria that would normally be cleared by the immune system take hold in tissue that has neither the oxygen nor the cellular resources to fight back.

The infection spreads. It reaches the bone. What began as a friction blister has become osteomyelitis, a bone infection that is extraordinarily difficult to treat in the setting of poor vascular supply.

At that point, the surgical team faces a stark equation. Restore blood flow if possible. Amputate if not. And if the disease has progressed far enough, if too much tissue is necrotic and too much infection has spread, even successful revascularization may not be enough to save the foot.

Who Is at Risk?

PAD does not discriminate, but it does have preferences. The condition is significantly more common in people over the age of 50, in smokers and former smokers, and in people with diabetes, high blood pressure, high cholesterol, or a history of cardiovascular disease.

An estimated 6.5 million Americans over the age of 40 have PAD. Globally, more than 200 million people are affected. Of those, a substantial percentage will never be screened. Many will never receive a diagnosis until a wound that will not heal sends them to an emergency room or a specialist, at which point the conversation shifts from prevention to damage control.

The Test That Changes Everything

The most important thing to understand about PAD and amputation is this: the chain of events described above is not inevitable. It can be interrupted. And the interruption begins with a simple, non-invasive test called the ankle-brachial index, or ABI.

The ABI test compares blood pressure measurements taken at the arm and at the ankle. In a healthy vascular system, those readings should be roughly equal. When the ankle pressure is significantly lower than the arm pressure, it indicates that arterial disease is reducing blood flow to the lower extremities.

The test takes minutes. It requires no needles, no contrast dye, no radiation. It can be performed in a primary care office, a podiatry practice, or a wound care clinic. And it can identify PAD years before it reaches the critical limb ischemia stage, when the amputation clock is already running.

Early detection changes the entire clinical picture. A patient identified with PAD can be placed on appropriate medical management, counseled on lifestyle modifications, monitored more closely, and referred for vascular intervention if needed. Wounds can be assessed with a different level of suspicion. Minor foot problems can be treated with the urgency they deserve in a compromised vascular environment.

A Path Forward: Detection Before Crisis

For clinicians who see high-risk patients, particularly podiatrists and wound care specialists who are often the first point of contact for patients with foot problems, routine vascular assessment is one of the highest-impact clinical habits available.

PAD will not announce itself. It will not show up on a routine exam unless someone is specifically looking for it. But it is there, in a substantial percentage of the patients walking through your door right now, progressing quietly toward a crisis that does not have to happen.

The technology to find it exists. The reimbursement structure to support it exists. The clinical evidence for early intervention exists.

The only thing missing is the test.

Learn More About simpleABI

simpleABI systems from Newman Medical bring fast, accurate ABI testing into the clinical workflow without disrupting patient flow. The simpleABI-400CL offers ABI testing, ABI-Q for diabetic patients, and TBI measurement for wound healing prognosis in a single platform. Podiatrists performing routine ABI testing average nearly $13,000 per year in CMS reimbursement, and the system pays for itself in under six months at just three studies per week.

Protect your patients from preventable amputation. Learn more about the simpleABI at newman-medical.com/vascular-abi-machines